综合性四年疾病进展评估的肌性发育不良症1型
Leandre A la Fontaine1, Johanna E Bruijnes1, Fran Hp Smulders2
1Department of Neurology, Maastricht University Medical Centre+, P. Debyelaan 25, Maastricht 6229 HX, the Netherlands; Mental Health and Neuroscience Research Institute, Maastricht University, Universiteitssingel 40, Maastricht 6229 ER, the Netherlands.
Neuromuscular disorders : NMD
|August 31, 2024
概括
在4年内,肌性缩症1型 (DM1) 进展显示肌肉衰弱和日常活动减少. 有趣的是,肌有所改善,这可能是由于DM1患者的握力下降.
科学领域:
- 神经学 神经学
- 遗传学 遗传学 是一个
- 临床医学 临床医学
背景情况:
- 肌性缩症1型 (DM1) 是一种复杂的神经肌肉疾病.
- 1型糖尿病的特征是逐渐肌肉衰弱和肌,影响日常生活.
- 了解DM1的进展对于患者的管理至关重要.
研究的目的:
- 研究DM1患者肌肉强度和功能的四年进展.
- 分析肌肉力量,肌和日常生活限制的变化.
- 确定影响DM1疾病进展的因素.
主要方法:
- 在4年内对187名DM1患者进行了长度研究.
- 评估肌肉强度 (MRC-sumscore),握力 (Martin-Vigorimeter),肌 (放松时间) 和日常活动 (DM1Activ).
- 统计分析以确定疾病进展模式和影响因素.
主要成果:
- 肌肉强度显著下降,特别是在远部肌肉.
- 手握力下降,根据性别和表型有所不同.
- 观察到肌的改善,与握力下降相关.
- 降低的DM1ActivC分数表明活动和社会参与减少.
结论:
- DM1的进展是异质的,受性别,表型和疾病状态的影响.
- 结合多个结果指标对于全面了解DM1.1至关重要.
- 这项研究强调了细微的疾病进展,需要量身定制的患者护理策略.
相关概念视频
Myasthenia Gravis: Diagnostic Tests
705
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
705
Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K
Disorders of the Skeletal Muscle
905
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
905
Satellite Stem Cells and Muscular Dystrophy
1.9K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
1.9K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K


